Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Acquisitions (2016 - 2025)

Historic Acquisitions for Bristol Myers Squibb (BMYMP) over the last 15 years, with Q4 2025 value amounting to $1.7 billion.

  • Bristol Myers Squibb's Acquisitions rose 353191.49% to $1.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $3.9 billion, marking a year-over-year decrease of 8192.57%. This contributed to the annual value of $3.9 billion for FY2025, which is 8192.57% down from last year.
  • Per Bristol Myers Squibb's latest filing, its Acquisitions stood at $1.7 billion for Q4 2025, which was up 353191.49% from $1.9 billion recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Acquisitions ranged from a high of $20.1 billion in Q1 2024 and a low of $35.0 million during Q1 2021
  • Moreover, its 5-year median value for Acquisitions was $357.0 million (2021), whereas its average is $1.6 billion.
  • Its Acquisitions has fluctuated over the past 5 years, first soared by 2560897.44% in 2024, then crashed by 9961.1% in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Acquisitions (Quarter) stood at $152.0 million in 2021, then dropped by 23.68% to $116.0 million in 2022, then surged by 400.86% to $581.0 million in 2023, then crashed by 91.91% to $47.0 million in 2024, then skyrocketed by 3531.91% to $1.7 billion in 2025.
  • Its Acquisitions was $1.7 billion in Q4 2025, compared to $1.9 billion in Q3 2025 and $285.0 million in Q2 2025.